Shelter Pharma shares rise 14% on securing order from international client

In a filing to the stock exchanges, the company said that it has secured an order worth $1,20,000 from Berlin International Medical Company.

The company informed the stock exchanges that the order includes a range of pharmaceutical products, such as D3Cure 50 ml (30,000 pieces), FerroCure Capsule (30,000 pieces), CoughNill 200ml (10,000 pieces), Stonyl (10,000 pieces), and RoyalForte Capsule (10,000 pieces).

The pharma major said that the order will be executed within 3 months.

Earlier this week on June 4, Shelter Pharma received an order from Genet International, a company based in Bangladesh, for various pharmaceutical products. The total value of the order stood at $10,450 (approximately ₹8,72,406).

The company’s revenue from operations grew by 10.71% year-on-year for the full fiscal, climbing from ₹36.15 crore in FY23 to ₹40.02 crore in FY24. The net profits of the company increased by 19.23% to ₹6.2 crore in FY24 compared to ₹5.2 crore in FY23.

Shelter Pharma shares closed 7.59% higher at ₹52.73 apiece on the BSE after opening flat at ₹49 apiece. The stock has gained more than 4% in the past one week. Shelter Pharma’s market capitalisation stood at ₹60 crore.

Shelter Pharma is known for its herbal remedies, with its corporate office located in Ahmedabad, Gujarat. The company was established in 1965.